Get the Stockscreener App
3.95
0.75%
-0.03
After Hours:
3.95
Kezar Life Sciences Inc stock is traded at $3.95, with a volume of 3,749.
It is down -0.75% in the last 24 hours and up +1.28% over the past month.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
See More
Previous Close:
$3.98
Open:
$3.98
24h Volume:
3,749
Relative Volume:
0.07
Market Cap:
$29.29M
Revenue:
$7.00M
Net Income/Loss:
$-70.79M
P/E Ratio:
-0.4076
EPS:
-9.69
Net Cash Flow:
$-64.34M
1W Performance:
-2.95%
1M Performance:
+1.28%
6M Performance:
-32.59%
1Y Performance:
-30.34%
1-Day Range:
$3.925
$4.00
1-Week Range:
$3.925
$4.10
52-Week Range:
$3.6201
$9.18
Kezar Life Sciences Inc Stock (KZR) Company Profile
Name
Kezar Life Sciences Inc
Sector
Industry
Phone
650-822-5600
Address
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare KZR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
3.95 | 29.29M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-16-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-08-21 | Initiated | Wells Fargo | Overweight |
| Jul-16-18 | Initiated | Jefferies | Buy |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
| Jul-16-18 | Initiated | William Blair | Outperform |
View All
Kezar Life Sciences Inc Stock (KZR) Latest News
Kezar Life Sciences (NASDAQ:KZR) Upgraded to “Sell” at Wall Street Zen - Defense World
Real time scanner hits for Kezar Life Sciences Inc. explained2025 Price Targets & Smart Money Movement Alerts - Newser
What’s the recovery path for long term holders of Kezar Life Sciences Inc.Trade Exit Summary & Reliable Price Breakout Alerts - Newser
Using Python tools to backtest Kezar Life Sciences Inc. strategiesQuarterly Earnings Summary & Long-Term Safe Investment Ideas - Newser
Why Kezar Life Sciences Inc. is moving todayMarket Trend Report & Verified High Yield Trade Plans - Newser
What earnings revisions data tells us about Kezar Life Sciences Inc.2025 Top Decliners & Risk Controlled Daily Plans - Newser
Kezar Life Sciences Inc. stock trendline breakdown2025 Market Sentiment & AI Forecast Swing Trade Picks - Newser
Using fundamentals and technicals on Kezar Life Sciences Inc.Market Risk Analysis & High Accuracy Swing Entry Alerts - Newser
What candlestick patterns are forming on Kezar Life Sciences Inc.Portfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Is Kezar Life Sciences Inc. stock entering bullish territoryWeekly Loss Report & Real-Time Volume Analysis - Newser
Analyzing net buyer seller activity in Kezar Life Sciences Inc.July 2025 Reactions & Verified Swing Trading Watchlist - Newser
Kezar Life Sciences Inc. stock volume spike explainedTrade Signal Summary & Verified Stock Trade Ideas - Newser
Should you hold or exit Kezar Life Sciences Inc. nowWeekly Market Report & Daily Technical Stock Forecast Reports - Newser
How to track smart money flows in Kezar Life Sciences Inc.2025 Market Overview & Smart Allocation Stock Reports - Newser
Does Kezar Life Sciences Inc. qualify in momentum factor screeningWeekly Profit Analysis & Low Risk Profit Maximizing Plans - Newser
What the charts say about Kezar Life Sciences Inc. todayMarket Risk Analysis & Weekly High Return Opportunities - Newser
Custom watchlist performance reports with Kezar Life Sciences Inc.Chart Signals & Safe Capital Investment Plans - Newser
can technical indicators confirm kezar life sciences inc.’s reversalJuly 2025 Institutional & Verified Short-Term Plans - Newser
Applying Wyckoff theory to Kezar Life Sciences Inc. stock2025 Dividend Review & Consistent Return Strategy Ideas - Newser
what to expect from kezar life sciences inc. in the next 30 daysJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
Can Kezar Life Sciences Inc. hit a new high this monthJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser
Can Kezar Life Sciences Inc. ride the EV wave2025 Pullback Review & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Can Kezar Life Sciences Inc. maintain its current growth rateJuly 2025 PostEarnings & Long-Term Capital Growth Strategies - خودرو بانک
Is Kezar Life Sciences Inc. likely to announce a buybackJuly 2025 Levels & Fast Moving Market Watchlists - خودرو بانک
What’s the RSI of Kezar Life Sciences Inc. stockJuly 2025 Summary & Community Consensus Trade Alerts - خودرو بانک
Does Kezar Life Sciences Inc. have a sustainable dividendEarnings Risk Report & Accurate Entry/Exit Alerts - خودرو بانک
Is Kezar Life Sciences Inc. exposed to political risk2025 Year in Review & Technical Pattern Based Signals - خودرو بانک
Regression analysis insights on Kezar Life Sciences Inc. performance2025 Market Outlook & High Yield Stock Recommendations - Newser
Technical signs of recovery in Kezar Life Sciences IncMarket Movement Recap & Low Risk Investment Opportunities - Newser
Is Kezar Life Sciences Inc. stock ready for a breakout2025 Buyback Activity & Entry Point Confirmation Alerts - Newser
Exit strategy if you’re trapped in Kezar Life Sciences Inc.Quarterly Earnings Summary & Target Return Focused Stock Picks - Newser
Forecasting Kezar Life Sciences Inc. price range with options dataQuarterly Risk Review & Long-Term Capital Growth Strategies - Newser
Signal strength of Kezar Life Sciences Inc. stock in tech scannersOil Prices & Smart Swing Trading Alerts - Newser
Risk On: Should you avoid Kezar Life Sciences Inc. stock right nowInsider Buying & AI Forecast for Swing Trade Picks - خودرو بانک
Detecting support and resistance levels for Kezar Life Sciences Inc.Weekly Earnings Recap & Real-Time Stock Price Movement Reports - Newser
Is Kezar Life Sciences Inc. a potential multi bagger2025 Momentum Check & Long-Term Growth Portfolio Plans - خودرو بانک
Kezar Life Sciences Inc Stock (KZR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):